Trial Profile
Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon omega (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 Sep 2007 The expected completion date for this trial is now 1 Dec 2006.
- 22 Aug 2007 Status change from in progress to completed.
- 15 Apr 2007 Interim results have been presented.